Literature DB >> 19184344

The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva.

E Zampeli1, R L Thurmond, E Tiligada.   

Abstract

OBJECTIVES: Although the H(4) receptor localisation in the eye is unresolved, this study aimed to investigate the effects of the H(4) receptor antagonist JNJ7777120 in a model of experimental conjunctivitis.
METHODS: JNJ7777120, at 0.005-1 mmol/l, was instilled into the lower conjunctival fornix of normal and compound 48/80 (C48/80)-challenged eyes of male Wistar rats, in the absence or presence of 40 mg/ml disodium cromoglycate (DSCG). Conjunctival histamine content was quantified 20 min post-challenge. Statistical analyses were performed by ANOVA.
RESULTS: JNJ7777120 increased dose-dependently (r = 0.784, p < 0.001) the conjunctival histamine content. In the C48/80-challenged eye no effect of the antagonist was observed. Co-administration of JNJ7777120 with DSCG resulted in a biphasic action of JNJ7777120, implying a competitive action of the two agents.
CONCLUSIONS: These data suggest a functionality of the H(4) receptor in the rat eye and address questions on the localization and the role of the receptor in ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184344     DOI: 10.1007/s00011-009-8245-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  8 in total

Review 1.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

2.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

3.  Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo.

Authors:  Konstantinos Kyriakidis; Evangelia Zampeli; Marina Palaiologou; Dina Tiniakos; Ekaterini Tiligada
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 4.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 5.  Histamine pharmacology: from Sir Henry Dale to the 21st century.

Authors:  Ekaterini Tiligada; Madeleine Ennis
Journal:  Br J Pharmacol       Date:  2018-12-02       Impact factor: 8.739

6.  Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Authors:  Jack V Greiner; Kimberly Edwards-Swanson; Avner Ingerman
Journal:  Clin Ophthalmol       Date:  2011-01-13

7.  Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readouts.

Authors:  Uwe Nordemann; David Wifling; David Schnell; Günther Bernhardt; Holger Stark; Roland Seifert; Armin Buschauer
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.

Authors:  Eugene B McLaurin; Nicholas P Marsico; Stacey L Ackerman; Joseph B Ciolino; Julia M Williams; Linda Villanueva; David A Hollander
Journal:  Adv Ther       Date:  2014-09-27       Impact factor: 3.845

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.